Literature DB >> 19637289

Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss.

Nathan A Johnson1, Toos Sachinwalla, David W Walton, Kate Smith, Ashley Armstrong, Martin W Thompson, Jacob George.   

Abstract

UNLABELLED: Weight loss remains the most common therapy advocated for reducing hepatic lipid in obesity and nonalcoholic fatty liver disease. Yet, reduction of body weight by lifestyle intervention is often modest, and thus, therapies which effectively modulate the burden of fatty liver but are not contingent upon weight loss are of the highest practical significance. However, the effect of aerobic exercise on liver fat independent of weight loss has not been clarified. We assessed the effect of aerobic exercise training on hepatic, blood, abdominal and muscle lipids in 19 sedentary obese men and women using magnetic resonance imaging and proton magnetic resonance spectroscopy ((1)H-MRS). Four weeks of aerobic cycling exercise, in accordance with current physical activity guidelines, significantly reduced visceral adipose tissue volume by 12% (P < 0.01) and hepatic triglyceride concentration by 21% (P < 0.05). This was associated with a significant (14%) reduction in plasma free fatty acids (P < 0.05). Exercise training did not alter body weight, vastus lateralis intramyocellular triglyceride concentration, abdominal subcutaneous adipose tissue volume, (1)H-MRS-measured hepatic lipid saturation, or HOMA-IR (homeostasis model assessment of insulin resistance; P > 0.05).
CONCLUSION: These data provide the first direct experimental evidence demonstrating that regular aerobic exercise reduces hepatic lipids in obesity even in the absence of body weight reduction. Physical activity should be strongly promoted for the management of fatty liver, the benefits of which are not exclusively contingent upon weight loss.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19637289     DOI: 10.1002/hep.23129

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  186 in total

1.  Estrogen receptor-α signaling maintains immunometabolic function in males and is obligatory for exercise-induced amelioration of nonalcoholic fatty liver.

Authors:  Nathan C Winn; Thomas J Jurrissen; Zachary I Grunewald; Rory P Cunningham; Makenzie L Woodford; Jill A Kanaley; Dennis B Lubahn; Camila Manrique-Acevedo; R Scott Rector; Victoria J Vieira-Potter; Jaume Padilla
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-12-04       Impact factor: 4.310

2.  Adenovirus-36 seropositivity enhances effects of nutritional intervention on obesity, bright liver, and insulin resistance.

Authors:  Guglielmo M Trovato; Giuseppe Fabio Martines; Francesca M Trovato; Clara Pirri; Patrizia Pace; Adriana Garozzo; Angelo Castro; Daniela Catalano
Journal:  Dig Dis Sci       Date:  2011-09-28       Impact factor: 3.199

Review 3.  Exercise and the Regulation of Hepatic Metabolism.

Authors:  Elijah Trefts; Ashley S Williams; David H Wasserman
Journal:  Prog Mol Biol Transl Sci       Date:  2015-08-05       Impact factor: 3.622

Review 4.  Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials.

Authors:  G Musso; M Cassader; F Rosina; R Gambino
Journal:  Diabetologia       Date:  2012-01-27       Impact factor: 10.122

5.  Elevation of alanine transaminase and markers of liver fibrosis after a mixed meal challenge in individuals with type 2 diabetes.

Authors:  E Y H Khoo; M C Stevenson; E Leverton; R Cross; J W Eriksson; S M Poucher; I Spendlove; P G Morris; I A Macdonald; P Mansell; G P Aithal
Journal:  Dig Dis Sci       Date:  2012-05-17       Impact factor: 3.199

Review 6.  The Effects of Physical Exercise on Fatty Liver Disease.

Authors:  Dirk J van der Windt; Vikas Sud; Hongji Zhang; Allan Tsung; Hai Huang
Journal:  Gene Expr       Date:  2017-12-06

7.  Combining metformin and aerobic exercise training in the treatment of type 2 diabetes and NAFLD in OLETF rats.

Authors:  Melissa A Linden; Justin A Fletcher; E Matthew Morris; Grace M Meers; Monica L Kearney; Jacqueline M Crissey; M Harold Laughlin; Frank W Booth; James R Sowers; Jamal A Ibdah; John P Thyfault; R Scott Rector
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-12-10       Impact factor: 4.310

Review 8.  Physical activity, cardiorespiratory fitness, and exercise training in primary and secondary coronary prevention.

Authors:  Damon L Swift; Carl J Lavie; Neil M Johannsen; Ross Arena; Conrad P Earnest; James H O'Keefe; Richard V Milani; Steven N Blair; Timothy S Church
Journal:  Circ J       Date:  2013-01-18       Impact factor: 2.993

Review 9.  Nonalcoholic fatty liver disease: current issues and novel treatment approaches.

Authors:  Romina Lomonaco; Nishanth E Sunny; Fernando Bril; Kenneth Cusi
Journal:  Drugs       Date:  2013-01       Impact factor: 9.546

10.  Aerobic exercise but not resistance exercise reduces intrahepatic lipid content and visceral fat and improves insulin sensitivity in obese adolescent girls: a randomized controlled trial.

Authors:  SoJung Lee; Anthony R Deldin; David White; YoonMyung Kim; Ingrid Libman; Michelle Rivera-Vega; Jennifer L Kuk; Sandra Sandoval; Chris Boesch; Silva Arslanian
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-09-17       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.